Financial Management Professionals’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.76K Buy
100
+47
+89% +$2.7K ﹤0.01% 664
2026
Q1
$3.21K Sell
53
-3
-5% -$175 ﹤0.01% 666
2025
Q4
$3.02K Sell
56
-19
-25% -$914 ﹤0.01% 668
2025
Q3
$3.38K Sell
75
-56
-43% -$2.62K ﹤0.01% 640
2025
Q2
$6.06K Sell
131
-373
-74% -$18.3K ﹤0.01% 606
2025
Q1
$30.7K Buy
504
+102
+25% +$5.95K ﹤0.01% 333
2024
Q4
$22.7K Buy
402
+18
+5% +$1.01K ﹤0.01% 386
2024
Q3
$20K Buy
384
+71
+23% +$3.33K ﹤0.01% 420
2024
Q2
$13K Buy
313
+123
+65% +$5.5K ﹤0.01% 450
2024
Q1
$10K Sell
190
-81
-30% -$4.13K ﹤0.01% 531
2023
Q4
$14K Sell
271
-3,322
-92% -$174K ﹤0.01% 479
2023
Q3
$209K Sell
3,593
-473
-12% -$29K 0.04% 113
2023
Q2
$260K Sell
4,066
-1,322
-25% -$88.6K 0.04% 106
2023
Q1
$373K Buy
5,388
+961
+22% +$67.8K 0.07% 83
2022
Q4
$319K Buy
4,427
+499
+13% +$37.6K 0.07% 84
2022
Q3
$279K Sell
3,928
-1,463
-27% -$106K 0.06% 75
2022
Q2
$415K Buy
5,391
+222
+4% +$16.9K 0.1% 62
2022
Q1
$378K Buy
5,169
+2,866
+124% +$192K 0.08% 69
2021
Q4
$144K Sell
2,303
-29
-1% -$1.7K 0.03% 125
2021
Q3
$138K Buy
2,332
+124
+6% +$8.17K 0.03% 112
2021
Q2
$148K Buy
2,208
+248
+13% +$16.2K 0.04% 109
2021
Q1
$124K Buy
1,960
+548
+39% +$34.1K 0.03% 105
2020
Q4
$88K Sell
1,412
-96
-6% -$5.9K 0.02% 141
2020
Q3
$91K Buy
1,508
+7
+0.5% +$421 0.03% 118
2020
Q2
$88K Buy
1,501
+1,224
+442% +$73.2K 0.03% 115
2020
Q1
$15K Sell
277
-51
-16% -$3.12K 0.01% 150
2019
Q4
$21K Buy
328
+127
+63% +$7.27K 0.01% 142
2019
Q3
$10K Buy
201
+51
+34% +$2.4K ﹤0.01% 179
2019
Q2
$7K Hold
150
﹤0.01% 216
2019
Q1
$7K Hold
150
﹤0.01% 180
2018
Q4
$8K Hold
150
0.01% 161
2018
Q3
$9K Hold
150
﹤0.01% 182
2018
Q2
$8K Hold
150
﹤0.01% 170
2018
Q1
$9K Hold
150
﹤0.01% 167
2017
Q4
$9K Hold
150
﹤0.01% 136
2017
Q3
$9K Hold
150
﹤0.01% 138
2017
Q2
$8K Hold
150
﹤0.01% 163
2017
Q1
$8K Hold
150
﹤0.01% 182
2016
Q4
$8K Hold
150
﹤0.01% 174
2016
Q3
$8K Sell
150
-71
-32% -$4.56K ﹤0.01% 190
2016
Q2
$16K Buy
221
+71
+47% +$5.02K 0.01% 157
2016
Q1
$10K Hold
150
0.01% 146
2015
Q4
$10K Hold
150
0.01% 146
2015
Q3
$9K Hold
150
0.01% 164
2015
Q2
$9K Hold
150
﹤0.01% 173
2015
Q1
$10K Hold
150
﹤0.01% 176
2014
Q4
$9K Hold
150
0.01% 192
2014
Q3
$7K Hold
150
﹤0.01% 187
2014
Q2
$7K Hold
150
﹤0.01% 183
2014
Q1
$8K Hold
150
0.01% 176
2013
Q4
$8K Hold
150
0.01% 184
2013
Q3
$7K Hold
150
﹤0.01% 192
2013
Q2
$7K Buy
+150
New +$6.51K 0.01% 190

Other funds holding BMY

Financial Management Professionals's BMY Position: Q2 2026 in Review

Financial Management Professionals increased its Bristol-Myers Squibb (BMY) stake by 89% in Q2 2026, buying an estimated $2.7K and bringing the position to 100 shares worth $5.76K. The position accounts for ﹤0.01% of the portfolio, ranked #664.

Financial Management Professionals first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $415K in Q2 2022. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Financial Management Professionals held 100 shares of Bristol-Myers Squibb worth $5.76K as of Q2 2026.
  • Financial Management Professionals bought 47 Bristol-Myers Squibb shares in Q2 2026, an estimated $2.7K.
  • Bristol-Myers Squibb made up ﹤0.01% of Financial Management Professionals's portfolio in Q2 2026, its #664 holding.
  • Financial Management Professionals first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
  • Financial Management Professionals's Bristol-Myers Squibb position peaked at $415K in Q2 2022.
  • 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Financial Management Professionals's 13F filing for Q2 2026, filed 9 Jul 2026.